Ticker: BEAM

Company: Beam Therapeutics Inc.

Person: Christine Bellon, officer

Transaction date: Jan. 15, 2026

Reporting date: Jan. 20, 2026

Average share price: 34.61439228622041

Sold 18629.0 shares for 644831.51